Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.080
+0.020 (1.89%)
Aug 13, 2025, 4:00 PM - Market closed
Cytosorbents Employees
Cytosorbents had 149 employees as of December 31, 2024. The number of employees decreased by 37 or -19.89% compared to the previous year.
Employees
149
Change (1Y)
-37
Growth (1Y)
-19.89%
Revenue / Employee
$242,332
Profits / Employee
-$66,214
Market Cap
67.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTSO News
- 5 days ago - Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 14 days ago - CytoSorbents Leads a New Era in Sepsis Treatment - PRNewsWire
- 16 days ago - CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 6 weeks ago - CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR - PRNewsWire
- 7 weeks ago - CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR - PRNewsWire
- 2 months ago - CytoSorbents to Participate at the Jefferies Global Healthcare Conference - PRNewsWire
- 3 months ago - CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025 - PRNewsWire